Cargando…

Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article

Molecular residual disease (MRD), detected by circulating tumor DNA (ctDNA) can be involved in the entire process of solid tumor management, including recurrence prediction, efficacy evaluation, and risk stratification. Currently, the detection technologies are divided into two main categories, as f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Qiantong, Chen, Chenbin, Hu, Yuanbo, Zhang, Weiteng, Yang, Xinxin, Qi, Yingxue, Zhu, Chan, Chen, Xiaodong, Shen, Xian, Ji, Weiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653633/ https://www.ncbi.nlm.nih.gov/pubmed/37955635 http://dx.doi.org/10.1080/15384047.2023.2274123

Ejemplares similares

Preoperative Fibrosis-4 (FIB-4) Evaluation May Be Helpful to Evaluate Prognosis of Gastric Cancer Patients Undergoing Operation: A Retrospective Study
por: Xu, Ke, et al.
Publicado: (2021)

Radiomics based on machine learning algorithms could predict prognosis and postoperative chemotherapy benefits of patients with gastric cancer: a retrospective cohort study
por: Xiang, Yilan, et al.
Publicado: (2023)

Global leaders malnutrition initiative-defined malnutrition affects long-term survival of different subgroups of patients with gastric cancer: A propensity score-matched analysis
por: Cai, Wentao, et al.
Publicado: (2022)

Preoperative Albumin-Bilirubin Grade as a Prognostic Predictor in Colorectal Cancer Patients Who Undergo Radical Resection
por: Zhu, Ce, et al.
Publicado: (2020)

Prognostic value of the preoperative albumin‐bilirubin score among patients with stages I–III gastric cancer undergoing radical resection: A retrospective study
por: Wang, Xiang, et al.
Publicado: (2023)

Establishment of the Radiologic Tumor Invasion Index Based on Radiomics Splenic Features and Clinical Factors to Predict Serous Invasion of Gastric Cancer
por: Pan, Bujian, et al.
Publicado: (2021)

The relationship between GLIM-malnutrition, post-operative complications and long-term prognosis in elderly patients undergoing colorectal cancer surgery
por: Shen, Ningzhe, et al.
Publicado: (2023)

Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer
por: Sun, Jing, et al.
Publicado: (2022)

Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
por: Peng, Yan, et al.
Publicado: (2021)

Detecting liquid remnants of solid tumors treated with curative intent: Circulating tumor DNA as a biomarker of minimal residual disease (Review)
por: Chen, Huijuan, et al.
Publicado: (2023)

Opposing biological functions of the cytoplasm and nucleus DAXX modified by SUMO-2/3 in gastric cancer
por: Chen, Chenbin, et al.
Publicado: (2020)

Minimal residual disease (MRD) detection in solid tumors using circulating tumor DNA: a systematic review
por: Zhu, Lemei, et al.
Publicado: (2023)

Sarcopenia in Patients With Normal Body Mass Index Is an Independent Predictor for Postoperative Complication and Long‐Term Survival in Gastric Cancer
por: Sun, Xiangwei, et al.
Publicado: (2021)

Preoperative Hyponatremia And Hypocalcemia Predict Poor Prognosis In Elderly Gastric Cancer Patients
por: Xu, Jingxuan, et al.
Publicado: (2019)

Impact of Circulating Tumor DNA–Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors
por: Kasi, Pashtoon M., et al.
Publicado: (2022)

Metabolic syndrome predicts postoperative complications after gastrectomy in gastric cancer patients: Development of an individualized usable nomogram and rating model
por: Chen, Xiaodong, et al.
Publicado: (2020)

Does the Low-Carbon City Pilot Policy Promote Green Technology Innovation? Based on Green Patent Data of Chinese A-Share Listed Companies
por: Ma, Jintao, et al.
Publicado: (2021)

Efficacy of the Preoperative Albumin–Bilirubin Grade for Predicting Survival and Outcomes of Postoperative Chemotherapy for Advanced Gastric Cancer
por: Zhu, Ce, et al.
Publicado: (2020)

Three-Dimensional Ex Vivo Culture for Drug Responses of Patient-Derived Gastric Cancer Tissue
por: Chen, Sian, et al.
Publicado: (2021)

Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer
por: Yuan, Shu‐Qiang, et al.
Publicado: (2023)

NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation
por: Hu, Yuanbo, et al.
Publicado: (2021)

The Human Cytomegalovirus US31 Gene Predicts Favorable Survival and Regulates the Tumor Microenvironment in Gastric Cancer
por: Ye, Sisi, et al.
Publicado: (2021)

Preoperative Blood Glucose Level Predicts Postsurgical Gastroparesis Syndrome after Subtotal Gastrectomy: Development of an Individualized Usable Nomogram
por: Mao, Chenchen, et al.
Publicado: (2020)

A quantified risk-scoring system including the visceral fat area for peritoneal metastasis of gastric cancer
por: Chen, Xiaodong, et al.
Publicado: (2019)

Research on Modular Management of Railway Bridge Technology Innovation in Complex and Difficult Mountainous Areas
por: Chen, Huihua, et al.
Publicado: (2022)

Integrated analysis of circulating tumour cells and circulating tumour DNA to detect minimal residual disease in hepatocellular carcinoma
por: Zhao, Lina, et al.
Publicado: (2022)

Technological Ecosystems in Health Informatics: A Brief Review Article
por: WU, Zhongmei, et al.
Publicado: (2016)

Using single-cell sequencing technology to detect circulating tumor cells in solid tumors
por: Xu, Jiasheng, et al.
Publicado: (2021)

Solid‐phase silica‐based extraction leads to underestimation of residual DNA in decellularized tissues
por: Schmitz, Tara C., et al.
Publicado: (2020)

Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer
por: Yang, Jian, et al.
Publicado: (2020)

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
por: Kurtz, David M., et al.
Publicado: (2021)

Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA
por: Semenkovich, Nicholas P, et al.
Publicado: (2023)

Municipal solid waste incinerator residues
Publicado: (1997)

Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer
por: Wang, Siwei, et al.
Publicado: (2022)

Correction to: Using single-cell sequencing technology to detect circulating tumor cells in solid tumors
por: Xu, Jiasheng, et al.
Publicado: (2022)

Monitoring of Measurable Residual Disease Using Circulating DNA after Allogeneic Hematopoietic Cell Transplantation
por: Waterhouse, Miguel, et al.
Publicado: (2022)

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
por: Sefrioui, David, et al.
Publicado: (2017)

Does Environmental Information Disclosure Improve the Health Level of Middle-Aged and Old Residents? Evidence From China
por: Yu, Xuan, et al.
Publicado: (2022)

Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers
por: Cha, Yongjun, et al.
Publicado: (2023)

Circulating Tumor DNA-Based Genomic Profiling Assays in Adult Solid Tumors for Precision Oncology: Recent Advancements and Future Challenges
por: Chan, Hiu Ting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_teqd031a47o0b910t1sg0tk7lb